Differential processing and secretion of Aβ peptides and sAPPα in human platelets is regulated by thrombin and prostaglandine 2

Neurobiology of Aging

Volumn 30, Issue 10, 2009, Pages 1552-1562

  Smirnov, A ^a   Trupp, A ^b   Henkel, A W ^a   Bloch, E ^b   Reulbach, U ^a   Lewczuk, P ^a   Riggert, J ^b   Kornhuber, J ^a   Wiltfang, J ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Amyloid peptides; Exocytosis; Human platelets; sAPP

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; PROSTAGLANDIN E2; SECRETED AMYLOID PRECURSOR PROTEIN AFTER ALPHA SECRETASE CUTTING; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; REGULATORY MECHANISM; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; BLOOD PLATELETS; CELLS, CULTURED; COLLAGEN; DINOPROSTONE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXOCYTOSIS; EXTRACELLULAR SPACE; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SPACE; KINETICS; PEPTIDE FRAGMENTS; THROMBIN; TIME FACTORS;

EID: 69249202608     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.12.009     Document Type: Article

References (54)

1. Abraham C.R., Marshall D.C., Tibbles H.E., Otto K., Long H.J., Billingslea A.M., Hastey R., Johnson R., Fine R.E., Smith S.J., Simons E.R., and Davies T.A. Platelets and DAMI megakaryocytes possess beta-secretase-like activity. J. Lab. Clin. Med. 133 5 (1999) 507-515
2. Bateman D.A., McLaurin J., and Chakrabartty A. Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding. BMC Neurosci. 8 (2007) 29
3. Bibl M., Esselmann H., Mollenhauer B., and Wiltfang J. Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer's disease. Neuroscience 146 1 (2007) 17-18
4. Bibl M., Esselmann H., Otto M., Lewczuk P., Cepek L., Ruther E., Kornhuber J., and Wiltfang J. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides. Electrophoresis 25 17 (2004) 2912-2918
5. Bibl M., Mollenhauer B., Esselmann H., Lewczuk P., Trenkwalder C., Brechlin P., Ruther E., Kornhuber J., Otto M., and Wiltfang J. CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. J. Neural. Transm. 113 11 (2006) 1771-1778
6. Bibl M., Mollenhauer B., Lewczuk P., Esselmann H., Wolf S., Trenkwalder C., Otto M., Stiens G., Ruther E., Kornhuber J., and Wiltfang J. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol. Psychiatry (2007)
7. Blennow K., and Vanmechelen E. CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry. Brain Res. Bull. 61 3 (2003) 235-242
8. Borroni B., Colciaghi F., Corsini P., Akkawi N., Rozzini L., Del Zotto E., Talarico G., Cattabeni F., Lenzi G.L., Di Luca M., and Padovani A. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. Neurol. Sci. 23 5 (2002) 207-210
9. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., Currie J., Ames D., Weidemann A., Fischer P., et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 265 26 (1990) 15977-15983
10. Casoli T., Di Stefano G., Giorgetti B., Grossi Y., Balietti M., Fattoretti P., and Bertoni-Freddari C. Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology. Ann. N.Y. Acad. Sci. 1096 (2007) 170-178
11. Chen M., Inestrosa N.C., Ross G.S., and Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun. 213 1 (1995) 96-103
12. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., and Di Luca M. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 8 2 (2002) 67-74
13. Da Prada M., Cesura A.M., Launay J.M., and Richards J.G. Platelets as a model for neurones?. Experientia 44 2 (1988) 115-126
14. Davies T.A., Long H.J., Eisenhauer P.B., Hastey R., Cribbs D.H., Fine R.E., and Simons E.R. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system. Amyloid 7 3 (2000) 153-165
15. DeMayer. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease. Cariovasc. Hematol. Disord. Drug Targets 6 (2006) 21-34
16. Di Luca M., Colciaghi F., Pastorino L., Borroni B., Padovani A., and Cattabeni F. Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein. Eur. J. Pharmacol. 405 1-3 (2000) 277-283
17. Di Luca M., Pastorino L., Bianchetti A., Perez J., Vignolo L.A., Lenzi G.L., Trabucchi M., Cattabeni F., and Padovani A. Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch. Neurol. 55 9 (1998) 1195-1200
18. Eckert A., Cotman C.W., Zerfass R., Hennerici M., and Muller W.E. Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered. J. Neural. Transm. Suppl. 54 (1998) 259-267
19. Evin G., Zhu A., Holsinger R.M., Masters C.L., and Li Q.X. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. J. Neurosci. Res. 74 3 (2003) 386-392
20. Giri R., Selvaraj S., Miller C.A., Hofman F., Yan S.D., Stern D., Zlokovic B.V., and Kalra V.K. Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am. J. Physiol. Cell Physiol. 283 3 (2002) C895-C904
21. 2 analogue, on human blood platelet behaviour and vascular contractility. Eur. J. Pharmacol. 114 2 (1985) 129-137
22. Handagama P., Bainton D.F., Jacques Y., Conn M.T., Lazarus R.A., and Shuman M.A. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J. Clin. Invest. 91 1 (1993) 193-200
23. Hartmann T. Intracellular biology of Alzheimer's disease amyloid beta peptide. Eur. Arch. Psychiatry Clin. Neurosci. 249 6 (1999) 291-298
24. Hedin H.L., Eriksson S., and Fowler C.J. Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in Alzheimer's disease. Neurochem. Int. 38 2 (2001) 145-151
25. Jans D.M., Martinet W., Fillet M., Kockx M.M., Merville M.P., Bult H., Herman A.G., and De Meyer G.R. Effect of non-steroidal anti-inflammatory drugs on amyloid-beta formation and macrophage activation after platelet phagocytosis. J. Cardiovasc. Pharmacol. 43 3 (2004) 462-470
26. Jolly-Tornetta C., and Wolf B.A. Regulation of amyloid precursor protein (APP) secretion by protein kinase calpha in human ntera 2 neurons (NT2N). Biochemistry 39 25 (2000) 7428-7435
27. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., and Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331 6156 (1988) 530-532
28. Kowalska M.A., and Badellino K. beta-Amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem. Biophys. Res. Commun. 205 3 (1994) 1829-1835
29. Lewczuk P., Esselmann H., Bibl M., Paul S., Svitek J., Miertschischk J., Meyrer R., Smirnov A., Maler J.M., Klein C., Otto M., Bleich S., Sperling W., Kornhuber J., Ruther E., and Wiltfang J. Electrophoretic separation of amyloid beta peptides in plasma. Electrophoresis 25 20 (2004) 3336-3343
30. Lewczuk P., Kornhuber J., Vanderstichele H., Vanmechelen E., Esselmann H., Bibl M., Wolf S., Otto M., Reulbach U., Kolsch H., Jessen F., Schroder J., Schonknecht P., Hampel H., Peters O., Weimer E., Perneczky R., Jahn H., Luckhaus C., Lamla U., Supprian T., Maler J.M., and Wiltfang J. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol. Aging (2007)
31. Li Q.-X., Cappai R., Evin G., Tanner J.E., Gray C.W., Beyreuther K., and Masters C.L. Products of the Alzheimer's disease amyloid precursor protein generated by β-secretase are present in human platelets, and secreted upon degranulation. Am. J. Alzheimer's Dis. 13 (1998) 236-244
32. Li Q., Berndt M., Bush A.I., Rumble B., Mackenzie I., Friedhuber A., Beyreuther K., and Masters C. Membrane associated forms of that βA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain:surface expression on the activated human platelets. Blood 84 1 (1994) 133-142
33. Li Q.X., Fuller S.J., Beyreuther K., and Masters C.L. The amyloid precursor protein of Alzheimer disease in human brain and blood. J. Leukoc. Biol. 66 4 (1999) 567-574
34. Mattson M.P. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. N.Y. Acad. Sci. 747 (1994) 50-76
35. Milward E.A., Papadopoulos R., Fuller S.J., Moir R.D., Small D., Beyreuther K., and Masters C.L. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9 1 (1992) 129-137
36. Mönning U., König G., Prior R., Mechler H., Schreiter-Gasser U., Masters C.L., and Beyreuther K. Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Lett. 277 1-2 (1990) 261-266
37. Pluta R. Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival. Acta Neurochir. Suppl. 86 (2003) 117-122
38. Prodan C.I., Ross E.D., Vincent A.S., and Dale G.L. Coated-platelets are Higher in Amnestic Versus Nonamnestic Patients With Mild Cognitive Impairment. Alzheimer Dis. Assoc. Disord. 21 3 (2007) 259-261
39. Prodan C.I., Szasz R., Vincent A.S., Ross E.D., and Dale G.L. Coated-platelets retain amyloid precursor protein on their surface. Platelets 17 1 (2006) 56-60
40. Savage M.J., Trusko S.P., Howland D.S., Pinsker L.R., Mistretta S., Reaume A.G., Greenberg B.D., Siman R., and Scott R.W. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18 5 (1998) 1743-1752
41. Schlossmacher M.G., Ostaszewski B.L., Hecker L.I., Celi A., Haass C., Chin D., Lieberburg I., Furie B.C., Furie B., and Selkoe D.J. Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes. Neurobiol. Aging 13 3 (1992) 421-434
42. Schmaier A.H., Dahl L.D., Hasan A.A., Cines D.B., Bauer K.A., and Van Nostrand W.E. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes. Biochemistry 34 4 (1995) 1171-1178
43. Skovronsky D.M., Moore D.B., Milla M.E., Doms R.W., and Lee V.M. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J. Biol. Chem. 275 4 (2000) 2568-2575
44. Tang K., Hynan L.S., Baskin F., and Rosenberg R.N. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J. Neurol. Sci. 240 1-2 (2006) 53-58
45. Van Nostrand W.E., Schmaier A.H., Farrow J.S., Cines D.B., and Cunningham D.D. Protease nexin-2/amyloid beta-protein precursor in blood is a platelet-specific protein. Biochem. Biophys. Res. Commun. 175 1 (1991) 15-21
46. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J.M., Masters C.L., and Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57 1 (1989) 115-126
47. Weltzien R.B., and Pachter J.S. Visualization of beta-amyloid peptide (Abeta) phagocytosis by human mononuclear phagocytes: dependency on Abeta aggregate size. J. Neurosci. Res. 59 4 (2000) 522-527
48. Wiltfang J., Esselmann H., Bibl M., Hull M., Hampel H., Kessler H., Frolich L., Schroder J., Peters O., Jessen F., Luckhaus C., Perneczky R., Jahn H., Fiszer M., Maler J.M., Zimmermann R., Bruckmoser R., Kornhuber J., and Lewczuk P. Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J. Neurochem. 101 4 (2007) 1053-1059
49. Wiltfang J., Esselmann H., Bibl M., Smirnov A., Otto M., Paul S., Schmidt B., Klafki H.W., Maler M., Dyrks T., Bienert M., Beyermann M., Ruther E., and Kornhuber J. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J. Neurochem. 81 3 (2002) 481-496
50. Wiltfang J., Esselmann H., Smirnov A., Bibl M., Cepek L., Steinacker P., Mollenhauer B., Buerger K., Hampel H., Paul S., Neumann M., Maler M., Zerr I., Kornhuber J., Kretzschmar H.A., Poser S., and Otto M. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann. Neurol. 54 2 (2003) 263-267
51. Wiltfang J., Lewczuk P., Riederer P., Grunblatt E., Hock C., Scheltens P., Hampel H., Vanderstichele H., Iqbal K., Galasko D., Lannfelt L., Otto M., Esselmann H., Henkel A.W., Kornhuber J., and Blennow K. Consensus paper of the WFSBP task force on biological markers of dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J. Biol. Psychiatry 6 2 (2005) 69-84
52. Wiltfang J., Smirnov A., Schnierstein B., Kelemen G., Matthies U., Klafki H.W., Staufenbiel M., Hüther G., Rüther E., and Kornhuber J. Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis 18 3-4 (1997) 527-532
53. Xu F., Previti M.L., and Van Nostrand W.E. Increased severity of hemorrhage in transgenic mice expressing cerebral protease nexin-2/amyloid beta-protein precursor. Stroke 38 9 (2007) 2598-2601
54. Zimmermann M., Borroni B., Cattabeni F., Padovani A., and Di Luca M. Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients. Neurobiol. Dis. 19 1-2 (2005) 237-242